Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
7(64%)
Results Posted
25%(1 trials)

Phase Distribution

Ph not_applicable
6
55%
Ph phase_2
1
9%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
1(14.3%)
N/ANon-phased studies
6(85.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

7

trials recruiting

Total Trials

11

all time

Status Distribution
Active(7)
Completed(4)

Detailed Status

Recruiting5
Completed4
Active, not recruiting2

Development Timeline

Analytics

Development Status

Total Trials
11
Active
7
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (14.3%)
N/A6 (85.7%)

Trials by Status

completed436%
recruiting545%
active_not_recruiting218%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
OTHER
Total Trials
11